SCHEMBL2776004

SCHEMBL2776004

COC(=O)CCc1ccc(Nc2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.51
MAPT P10636 6/20 0.51
HPGD P15428 2/20 0.51
HTT P42858 2/20 0.51
ALOX12 P18054 1/20 0.51
MAPK1 P28482 1/20 0.51
SIRT2 Q8IXJ6 1/20 0.51
EPHX2 P34913 1/20 0.51
CA12 O43570 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50
IDO1 P14902 1/20 0.49
FFAR1 O14842 2/20 0.49
ALDH1A1 P00352 2/20 0.49
FFAR4 Q5NUL3 1/20 0.47
GAA P10253 2/20 0.47
HSP90AA1 P07900 1/20 0.47
POLB P06746 1/20 0.47
PTPN1 P18031 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14717782 0.93 EPHX2 (0.56) MAPTHPGDHTTSIRT2EPHX2
SCHEMBL6308951 0.92 FFAR1 (0.56) TDP1MAPTEPHX2CA12CA7
SCHEMBL14683408 0.89 SIRT2 (0.52) HPGDSIRT2EPHX2FFAR1ALDH1A1
SCHEMBL12431316 0.88 EPHX2 (0.45) TDP1MAPTHPGDMAPK1SIRT2
SCHEMBL7756814 0.87 FFAR1 (0.53) TDP1MAPTEPHX2IDO1FFAR1
Methyl 3-Phenylpropanoate SCHEMBL168711 0.86 TDP1 (0.68) TDP1MAPTHTTCA12CA7
SCHEMBL7760724 0.85 F2RL1 (0.63) TDP1MAPTHPGDHTTALOX12
SCHEMBL14685742 0.85 SIRT2 (0.51) TDP1MAPTHTTSIRT2EPHX2
Methyl 3-Phenylpropanoate SCHEMBL1893702 0.84 TDP1 (0.66) TDP1MAPTHTTCA12CA7
Methyl 3-Phenylpropanoate SCHEMBL27315471 0.84 TDP1 (0.66) TDP1MAPTHTTCA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9188885-B2 Reactive compound, charge transporting film, photoelectric conversion device, electrophotographic photoreceptor and method of producing the same, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2015-11-17 US disclosed
US-9188885-B2 Reactive compound, charge transporting film, photoelectric conversion device, electrophotographic photoreceptor and method of producing the same, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2015-11-17 US disclosed
US-9188885-B2 Reactive compound, charge transporting film, photoelectric conversion device, electrophotographic photoreceptor and method of producing the same, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2015-11-17 US disclosed
US-9188886-B2 Image holding member for image forming apparatus, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2015-11-17 US disclosed
US-9188886-B2 Image holding member for image forming apparatus, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2015-11-17 US disclosed
US-8936858-B2 Organic electroluminescent element and display FUJI XEROX CO., LTD. (JP) 2015-01-20 US disclosed
US-8936858-B2 Organic electroluminescent element and display FUJI XEROX CO., LTD. (JP) 2015-01-20 US disclosed
US-8900726-B2 2014-12-02 US disclosed
US-8900726-B2 2014-12-02 US disclosed
US-20140227005-A1 IMAGE HOLDING MEMBER FOR IMAGE FORMING APPARATUS, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2014-08-14 US disclosed
US-20080312453-A1 Novel Carbazole Compound, and Polymer Thereof FUJI XEROX CO., LTD. (JP) 2008-12-18 US disclosed
US-20080306239-A1 QUINOXALINE-CONTAINING COMPOUNDS AND POLYMERS THEREOF FUJI XEROX CO., LTD. (JP) 2008-12-11 US disclosed
US-20080306239-A1 QUINOXALINE-CONTAINING COMPOUNDS AND POLYMERS THEREOF FUJI XEROX CO., LTD. (JP) 2008-12-11 US disclosed
WO-2008147553-A1 TETRACYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE THE SCRIPPS RESEARCH INSTITUTE (US) 2008-12-04 WO disclosed
US-20070252519-A1 Novel thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium FUJI XEROX CO., LTD. (JP) 2007-11-01 US disclosed
US-20070252519-A1 Novel thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium FUJI XEROX CO., LTD. (JP) 2007-11-01 US disclosed
US-7060783-B2 Diamine compound polymer having condensed aromatic group FUJI XEROX CO., LTD. (JP) 2006-06-13 US disclosed
US-6942951-B2 Thermoelectrically transferring and fixing a toner image formed on an electrostatic latent image carrier without scattering of the toner FUJI XEROX CO., LTD. (JP) 2005-09-13 US disclosed
US-20050033011-A1 Diamine compound polymer having condensed aromatic group FUJI XEROX CO., LTD. (JP) 2005-02-10 US disclosed
US-20030091924-A1 Image forming method FUJI XEROX CO., LTD. (JP) 2003-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312453-A1 Novel Carbazole Compound, and Polymer Thereof ARL1, CDKL1, PARP11 TDP1 2566/4885MAPT 3035/4885HPGD 4409/4885
US-20080306239-A1 QUINOXALINE-CONTAINING COMPOUNDS AND POLYMERS THEREOF ARL1, NMRAL1, PDXK TDP1 2336/4885MAPT 2648/4885HPGD 2772/4885
US-20070252519-A1 Novel thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium ARL1, NOD1, NLRP1 TDP1 1775/4885MAPT 1563/4885HPGD 4758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.